Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (14)

2023

  1. Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 1, pp. 67-80

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2020

  1. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

  2. Holistic approach of the care of the infant with hypoxic-ischaemic encephalopathy in Spain

    Anales de Pediatria, Vol. 92, Núm. 5, pp. 286-296

  3. The persistent breach between evidence and practice in the prevention of surgical site infection. Qualitative study

    International Journal of Surgery

2019

  1. Topiramate plus cooling for hypoxic-ischemic encephalopathy: A randomized, controlled, multicenter, double-blinded trial

    Neonatology, Vol. 116, Núm. 1, pp. 76-84

2018

  1. Oxidative stress in perinatal asphyxia and hypoxic-ischaemic encephalopathy

    Anales de Pediatria, Vol. 88, Núm. 4, pp. 228.e1-228.e9

2017

  1. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

  2. Evolution of energy related metabolites in plasma from newborns with hypoxic-ischemic encephalopathy during hypothermia treatment

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2013

  1. Bevacizumab in advanced breast cancer: A new model for the assessment of activity in non-first-line treatment regimens

    Anti-Cancer Drugs, Vol. 24, Núm. 9, pp. 975-979

2012

  1. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study

    Journal of Medical Virology, Vol. 84, Núm. 6, pp. 947-956

2009

  1. Prognostic and predictive factors and genetic analysis of early breast cancer

    Clinical and Translational Oncology

2008

  1. Trans-facet joint approach to pulsed radiofrequency ablation of the L5 dorsal root ganglion in a patient with degenerative spondylosis and scoliosis

    Pain Practice, Vol. 8, Núm. 3, pp. 202-205